FDA Inspection 1299048 — Custom Converting, Inc.

Custom Converting, Inc. — FEI 3007219818

The FDA completed an inspection of Custom Converting, Inc. on January 16, 2026 in Oceanside, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 16, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oceanside, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
439121 CFR 211.180(e)(2)Items to cover on annual reviews